Clinical Trial Update: Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pembrolizumab with radiation for locally advanced head and neck squamous cell carcinoma in patients not eligible for cisplatin has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-03-19